These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

856 related items for PubMed ID: 21361740

  • 21. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile.
    Camposano SE, Major P, Halpern E, Thiele EA.
    Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386
    [Abstract] [Full Text] [Related]

  • 22. Adrenocorticotropic hormone for the treatment of West Syndrome in children.
    Shumiloff NA, Lam WM, Manasco KB.
    Ann Pharmacother; 2013 May; 47(5):744-54. PubMed ID: 23606552
    [Abstract] [Full Text] [Related]

  • 23. Vigabatrin and mental retardation in tuberous sclerosis: infantile spasms versus focal seizures.
    Yum MS, Lee EH, Ko TS.
    J Child Neurol; 2013 Mar; 28(3):308-13. PubMed ID: 22752486
    [Abstract] [Full Text] [Related]

  • 24. Clinical profile and treatment of infantile spasms using vigabatrin and ACTH--a developing country perspective.
    Ibrahim S, Gulab S, Ishaque S, Saleem T.
    BMC Pediatr; 2010 Jan 15; 10():1. PubMed ID: 20078871
    [Abstract] [Full Text] [Related]

  • 25. [West syndrome: aetiology, therapeutic options, clinical course and prognostic factors].
    Arce-Portillo E, Rufo-Campos M, Munoz-Cabello B, Blanco-Martinez B, Madruga-Garrido M, Ruiz-Del Portal L, Candau Fernandez-Mensaque R.
    Rev Neurol; 2011 Jan 16; 52(2):81-9. PubMed ID: 21271547
    [Abstract] [Full Text] [Related]

  • 26. Autistic regression associated with seizure onset in an infant with tuberous sclerosis.
    Humphrey A, Neville BG, Clarke A, Bolton PF.
    Dev Med Child Neurol; 2006 Jul 16; 48(7):609-11. PubMed ID: 16780633
    [Abstract] [Full Text] [Related]

  • 27. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.
    Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, O'Callaghan FJ, Verity CM, Osborne JP, United Kingdom Infantile Spasms Study.
    Lancet Neurol; 2005 Nov 16; 4(11):712-7. PubMed ID: 16239177
    [Abstract] [Full Text] [Related]

  • 28. Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial.
    Darke K, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Lux AL, Newton RW, O'Callaghan FJ, Verity CM, Osborne JP, trial steering committee on behalf of participating investigators.
    Arch Dis Child; 2010 May 16; 95(5):382-6. PubMed ID: 20457702
    [Abstract] [Full Text] [Related]

  • 29. [Efficacy of vigabatrin therapy for tuberous sclerosis with infantile spasms].
    Suzuki-Muromoto, S, Uematsu M, Sato H, Numata-Uematsu Y, Nakayama T, Kiluchi A, Kobayashi T, Hino-Fukuyo N, Kure S.
    No To Hattatsu; 2016 Nov 16; 48(6):413-9. PubMed ID: 30010289
    [Abstract] [Full Text] [Related]

  • 30. A plausible explanation for superiority of adreno-cortico-trophic hormone (ACTH) over oral corticosteroids in management of infantile spasms (West syndrome).
    Jaseja H.
    Med Hypotheses; 2006 Nov 16; 67(4):721-4. PubMed ID: 16781824
    [Abstract] [Full Text] [Related]

  • 31. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience.
    Schwarz MD, Li M, Tsao J, Zhou R, Wu YW, Sankar R, Wu JY, Hussain SA.
    Epilepsy Behav; 2016 Apr 16; 57(Pt A):29-33. PubMed ID: 26921595
    [Abstract] [Full Text] [Related]

  • 32. Cerebral MRI abnormalities associated with vigabatrin therapy.
    Pearl PL, Vezina LG, Saneto RP, McCarter R, Molloy-Wells E, Heffron A, Trzcinski S, McClintock WM, Conry JA, Elling NJ, Goodkin HP, de Menezes MS, Ferri R, Gilles E, Kadom N, Gaillard WD.
    Epilepsia; 2009 Feb 16; 50(2):184-94. PubMed ID: 18783433
    [Abstract] [Full Text] [Related]

  • 33. Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients.
    Jambaqué I, Chiron C, Dumas C, Mumford J, Dulac O.
    Epilepsy Res; 2000 Feb 16; 38(2-3):151-60. PubMed ID: 10642043
    [Abstract] [Full Text] [Related]

  • 34. Drug-choice in management of West syndrome (infantile spasms): Early ACTH treatment may offer a better prognostic outcome.
    Jaseja H.
    Med Hypotheses; 2008 Feb 16; 70(1):197-8. PubMed ID: 17590279
    [No Abstract] [Full Text] [Related]

  • 35. [Treatment of infantile spasms].
    Hansen LK, Rasmussen NH.
    Ugeskr Laeger; 2006 Apr 03; 168(14):1424-8. PubMed ID: 16584670
    [Abstract] [Full Text] [Related]

  • 36. [Vigabatrin in the treatment of infantile spasms].
    Backström M, Eriksson K, Koivikko M.
    Duodecim; 1995 Apr 03; 111(9):853-5. PubMed ID: 8681848
    [No Abstract] [Full Text] [Related]

  • 37. Improving Outcomes in Infantile Spasms: Role of Pharmacotherapy.
    Iyer A, Appleton R.
    Paediatr Drugs; 2016 Oct 03; 18(5):357-66. PubMed ID: 27541933
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society.
    Mackay MT, Weiss SK, Adams-Webber T, Ashwal S, Stephens D, Ballaban-Gill K, Baram TZ, Duchowny M, Hirtz D, Pellock JM, Shields WD, Shinnar S, Wyllie E, Snead OC, American Academy of Neurology, Child Neurology Society.
    Neurology; 2004 May 25; 62(10):1668-81. PubMed ID: 15159460
    [Abstract] [Full Text] [Related]

  • 40. Managing epilepsy in tuberous sclerosis complex.
    Thiele EA.
    J Child Neurol; 2004 Sep 25; 19(9):680-6. PubMed ID: 15563014
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 43.